Top Markets
Coin of the day
Myrexis, Inc. Myrexis, Inc.

Myrexis, Inc.

MYRX
Rank in Stocks #41163
Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially... Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.
Share Price
$0.0011
Last synced: 2026-08-12
Market Cap
$37.93K
Change (1 day)
10.00%
Change (1 year)
450.00%
Country
US
Trade Myrexis, Inc. (MYRX)
Revenue for Myrexis, Inc. (MYRX)
Revenue in Aug 2026 TTM: 0
According to Myrexis, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Myrexis, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors